As a new strategy for drug discovery and development, we propose here the establishment of drug re-proˆling strategy. In this strategy, the actions of existing medicines, whose safety and pharmacokinetic eŠects in humans have been conˆrmed already, are examined comprehensively at the molecular level and the results are used for the development of new medicines. For example, identiˆcation of the mechanisms underlying the side eŠects of medicines enables us to develop safer drugs. The results can also be used for developing existing drugs for use as medicines in treatment of other diseases. Promoting this research strategy could provide breakthroughs in drug discovery and development by pharmaceutical companies.

